Curapath
- CMO, CRO
Curapath is a leading CDMO specializing in advanced polymer and lipid-based solutions for therapeutic development. With deep expertise in drug delivery technologies, Curapath supports biopharmaceutical companies from early-stage research through clinical and commercial manufacturing. The company offers end-to-end services including custom synthesis, formulation development, process optimization, analytical testing, and GMP manufacturing. Curapath’s integrated approach ensures seamless scale-up and accelerated timelines, enabling partners to bring complex therapies to market efficiently. Focused on innovation, quality, and regulatory compliance, Curapath is trusted by clients developing mRNA, oligonucleotide, and nanoparticle-based therapeutics. Through scientific collaboration and technical excellence, Curapath empowers the next generation of precision medicines.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}